Celltrion to invest $520M for new plant in China

South Korea's Celltrion Inc. said it will spend 600 billion won (US$520 million) on its new plant in China over the next...

January 24, 2020 | Friday | News
Genialis, Oncologie to use precision medicine for gastric cancer

US based Genialis, a leader in applied data science for the development of precision medicines, has announced a collabor...

January 23, 2020 | Thursday | News
TenNor receives FDA ODD for treating prosthetic joint infections

China based TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designa...

January 22, 2020 | Wednesday | News
Chi-Med to stop pancreatic cancer trial upon early success

Hutchison China MediTech has announced that the independent Data Monitoring Committee (“IDMC”) of the P...

January 21, 2020 | Tuesday | News
Mindray to improve diagnostic confidence

China headquartered Mindray Medical, a leading global provider of medical devices and solutions, announces the release o...

January 20, 2020 | Monday | News
MEVION S250i Selected for New Proton Therapy Center at Chinese Hospital

Mevion Medical Systems has signed an agreement to sell a HyperSCAN® pen-scanning scanner to Jinshazhou Hos...

January 20, 2020 | Monday | News
Eisai launches anti cancer agent Halaven in China

Japan headquartered Eisai Co., Ltd. has announced that it has launched the in-house developed anticancer agent Halaven&r...

January 17, 2020 | Friday | News
FDF China to boost Chinese pharmaceutical enterprises

FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai New International Expo C...

January 16, 2020 | Thursday | News
WuXi Biologics and Bayer enter into acquisition agreement

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions fo...

January 16, 2020 | Thursday | News
Advances in Cell and Gene Therapy and Opportunities in China

GenScript Biotech Corp., a leading global biotechnology group and a pioneer in the field of gene synthesis, held its ina...

January 16, 2020 | Thursday | Opinion
Tsinghua Amgen Scholars Program 2020 calls for application

The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of H...

January 15, 2020 | Wednesday | News
PPD expands clinical capabilities in China

PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chin...

January 15, 2020 | Wednesday | News
Great Bay Bio injected with $2.5M of convertible note

Recently, Great Bay Bio signed off convertible note, and the company will be injected with 2.5 million USD by existing s...

January 14, 2020 | Tuesday | News
Adagene Completes $69 Million Series D Financing

China based Adagene, Inc., a clinical-stage, leading-edge oncology immunotherapy company driven by a powerful antibody d...

January 14, 2020 | Tuesday | News
EUSA Pharma, BeiGene partner for rare disease drug development

EUSA Pharma and BeiGene has announced that they have entered into an exclusive development and commercialization ag...

January 14, 2020 | Tuesday | News
Bio-Thera launches first Humira biosimilar in China

Bio-Thera Solutions, Ltd., a fully-integrated pharmaceutical company, has announced that QLETLI®, a biosimilar to Hu...

January 13, 2020 | Monday | News
WuXi Biologics inks strategic deal with Almirall in derma space

China based WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solut...

January 10, 2020 | Friday | News
Former Celgene Chairman and CEO Joins Antengene Board of Directors

The Antengene board has announced the appointment of Mr. Mark J. Alles as an independent director of the compa...

January 9, 2020 | Thursday | News